Pfizer boosts by $500 million the range of its research and development budget for spending on a potential vaccine for COVID-19 as well as evaluation of existing products. coronavirus
Revenues at the pharmaceutical giant were dented by the halt to non-essential surgeries, and Pfizer also ceased in-person meetings with healthcare professionals in many markets, impeding prescriptions of some new drugs.
Net income came in at $3.4 billion, 12% below last year, which translated into per-share results that topped analyst expectations.Pfizer confirmed its full-year forecasts for revenues and adjusted profits, while tweaking a number of other aspects of its outlook.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
PH eyes $500-M loan to help poor families, SMEsThe Philippines is seeking from the World Bank another $500-million loan to replenish funds being doled out to poor families and small businesses affected by the COVID-19 pandemic. | bendeveraINQ
Read more »
[ANALYSIS] How to support microenterprises, informal sector hit by coronavirus'We may already be seeing the positive effects of the quarantine in terms of containing COVID-19. However, its negative economic impact is undeniable.' iSpeak COVID19PH
Read more »
UK reports lowest coronavirus toll in weeks as Johnson returnsBritain on Sunday reported its lowest daily rise in coronavirus deaths in nearly 4 weeks as officials confirmed Prime Minister Boris Johnson had returned to Downing Street after recovering from the virus.
Read more »
Bangladesh garment factories reopen, defying virus lockdown
Read more »
Lockdowns ease amid promising drops in virus deaths
Read more »
SC petitioners refute OSG: COVID-19 cases in jails show inability to prevent virus spread
Read more »